2. Revenue Analysis
Revenue Overview
During Q1 2025, Alvio Labs operated in a pre-revenue capacity, focusing on product development and market preparation. No sales revenue was recorded during this period, which is consistent with the company's early-stage development timeline.
Revenue Breakdown by Category
| Revenue Category |
Q1 2025 (EUR) |
% of Total |
| Product Sales |
0.00 |
0% |
| Service Revenue |
0.00 |
0% |
| Other Income |
0.00 |
0% |
| Total Revenue |
0.00 |
0% |
Note: The company is currently in the product development phase. Revenue generation is expected to commence in subsequent quarters as the product reaches market readiness.
3. Expense Analysis
Cost of Sales
| Account |
Amount (EUR) |
Description |
| Cost of Goods Sold |
10,350.00 |
Direct costs associated with product development |
| Total Cost of Sales |
10,350.00 |
|
Operating Expenses
| Expense Category |
Amount (EUR) |
% of OpEx |
| Consulting & Accounting |
405.90 |
65.8% |
| Research & Development |
198.27 |
32.1% |
| Bank Fees |
10.00 |
1.6% |
| Office: Software Expenses |
2.68 |
0.4% |
| Total Operating Expenses |
616.85 |
100% |
Operating Expense Distribution
Consulting & Accounting
EUR 405.90
Research & Development
EUR 198.27
Software Expenses
EUR 2.68
Expense Trend Analysis
Key Insight: Operating expenses are well-controlled at EUR 616.85 for the quarter. The majority (65.8%) is allocated to consulting and accounting services, reflecting the company's focus on establishing proper financial and operational frameworks. R&D investment at 32.1% demonstrates commitment to product development.
4. Balance Sheet Summary
Assets
| Asset Category |
31 Mar 2025 (EUR) |
31 Mar 2024 (EUR) |
Change |
| Revolut EUR Main (Cash) |
532.14 |
0.00 |
+532.14 |
| Total Assets |
532.14 |
0.00 |
+532.14 |
Liabilities
| Liability Category |
31 Mar 2025 (EUR) |
31 Mar 2024 (EUR) |
| Accounts Payable |
405.90 |
0.00 |
| Director's Current Account - Shubham Jain |
13,993.09 |
0.00 |
| Director's Loan Account - Shubham Jain |
550.00 |
0.00 |
| Total Current Liabilities |
14,948.99 |
0.00 |
| Total Liabilities |
14,948.99 |
0.00 |
Equity
| Equity Component |
31 Mar 2025 (EUR) |
31 Mar 2024 (EUR) |
| Current Year Earnings |
(10,966.85) |
0.00 |
| Retained Earnings |
(3,450.00) |
0.00 |
| Total Equity |
(14,416.85) |
0.00 |
Balance Sheet Check: Total Assets (EUR 532.14) = Total Liabilities (EUR 14,948.99) + Total Equity (EUR -14,416.85). The negative equity position reflects accumulated losses typical of early-stage startups.
5. Cash Flow Summary
Cash Position Analysis
As of March 31, 2025, the company maintains a cash position of EUR 532.14 in the Revolut EUR Main account. The following table summarizes key cash movements during Q1 2025:
| Cash Flow Category |
Amount (EUR) |
Notes |
| Opening Cash Balance |
0.00 |
As of January 1, 2025 |
| Director Loans Received |
800.00 |
Capital injections from director |
| Revenue Commission Received |
40.00 |
Commission income |
| Operating Expenditures |
(307.86) |
Net cash outflows for operations |
| Closing Cash Balance |
532.14 |
As of March 31, 2025 |
Cash Flow Summary Table
Monthly Cash Flow Trend (Q1 2025)
| Month |
Cash In (EUR) |
Cash Out (EUR) |
Net Flow (EUR) |
| January 2025 |
0.00 |
0.00 |
0.00 |
| February 2025 |
0.00 |
0.00 |
0.00 |
| March 2025 |
840.00 |
(307.86) |
532.14 |
| Q1 2025 Total |
840.00 |
(307.86) |
532.14 |
Cash Position: The company maintains a positive cash balance of EUR 532.14. Director loans of EUR 800 have provided essential working capital during the pre-revenue phase. Cash burn rate is manageable with current reserves.
6. Key Financial Ratios
Liquidity Ratios
Current Ratio
0.04x
Current Assets / Current Liabilities
Quick Ratio
0.04x
(Cash + Receivables) / Current Liabilities
Cash Ratio
0.04x
Cash / Current Liabilities
Liquidity Note: Current liquidity ratios are below the ideal 1.0x threshold, which is expected for a pre-revenue startup. The company relies on director loans and future funding to meet short-term obligations.
Profitability Ratios
Gross Profit Margin
N/A
Gross Profit / Revenue
Operating Margin
N/A
Operating Income / Revenue
Net Profit Margin
N/A
Net Income / Revenue
Profitability Note: Profitability ratios are not applicable as the company has not yet generated revenue. These metrics will become meaningful once sales commence.
Leverage Ratios
Debt-to-Assets
28.1x
Total Liabilities / Total Assets
Debt-to-Equity
(1.04)x
Total Liabilities / Total Equity
Equity Ratio
(27.1)x
Total Equity / Total Assets
Leverage Note: The negative equity position results in unusual leverage ratios. This is typical for early-stage companies with accumulated losses. The company is primarily financed through director loans rather than external debt.
Efficiency Metrics
| Metric |
Value |
Benchmark |
Status |
| Monthly Burn Rate |
EUR 3,655.62 |
Varies by stage |
Under Review |
| Runway (months) |
0.15 |
12-18 months |
Critical |
| R&D as % of OpEx |
32.1% |
20-40% |
On Target |
7. Observations and Recommendations
Key Observations
1. Pre-Revenue Position: The company is appropriately positioned in the development phase with no revenue recorded. This aligns with the expected timeline for a technology startup in its first quarter of operations.
2. Controlled Operating Expenses: Operating expenses of EUR 616.85 demonstrate disciplined cost management. The allocation between consulting (65.8%) and R&D (32.1%) reflects appropriate prioritization of foundational business setup alongside product development.
3. Director Financing: Director loans totaling EUR 14,543.09 provide essential working capital. This structure is common in early-stage companies before external funding rounds.
4. Cash Position: The cash balance of EUR 532.14 provides limited runway. Additional funding or revenue generation will be required to sustain operations beyond the immediate short term.
Recommendations
Immediate Actions (Next 30 Days)
- Finalize product development milestones to enable revenue generation
- Establish formal funding plan to extend runway beyond current cash position
- Document director loan terms for proper governance and compliance
Short-Term Priorities (Q2 2025)
- Launch minimum viable product (MVP) to begin revenue generation
- Implement financial controls and reporting cadence
- Develop customer acquisition strategy with associated budget
- Prepare for potential seed funding round
Medium-Term Strategy (H2 2025)
- Achieve product-market fit and establish recurring revenue streams
- Reduce dependency on director financing through external investment
- Build financial reserves to support 12-18 month runway
- Establish key performance indicators for ongoing financial monitoring
Board Resolution
The board acknowledges the company's pre-revenue status and approves the current burn rate as appropriate for the development phase. The board recommends immediate action on funding strategy to ensure adequate runway for achieving revenue milestones.